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Dear Editor,
We are grateful to Passeri et al. for their comments on our case report of a spontaneous regression of a clival chordoma. Their similar experience with a patient who had regression of a radiographically consistent clival chordoma after an episode of inflammatory bullous dermatosis, from an underlying Mycobacterium marinum infection, lends further support to the concept that chordomas can regress. The potential to uncover the underlying mechanisms of regression and tumor response in these reports can hopefully guide further drug discovery and screening in chordoma research.
However, despite the regression seen in these two reported cases, we would still recommend surgical resection over conservative follow-up imaging in a case such as the one they present. Maximal cytoreductive surgery and post-operative radiation are currently the most effective treatments for chordoma [1, 3] . While the patient in their case is currently asymptomatic, the size of the tumor and extent of brainstem compression present a significant risk for future deterioration. If this tumor were to grow, it could cause permanent irreversible deficits and the surgery would be more challenging and riskier at that point. The fact that the tumor has now partially decreased in size also makes it more amenable to surgical resection. Confirmatory pathology and histologic assessment could also lend support to an underlying mechanism of regression in their case. Resection through an endoscopic endonasal approach could be considered [2, 4] .
